Holen Sie sich die Stockscreener-App
0.6632
3.88%
-0.0268
Vorhandelsmarkt:
.72
0.0568
+8.56%
Schlusskurs vom Vortag:
$0.69
Offen:
$0.72
24-Stunden-Volumen:
265.57K
Relative Volume:
1.23
Marktkapitalisierung:
$71.36M
Einnahmen:
$1.29M
Nettoeinkommen (Verlust:
$-29.87M
KGV:
-1.8422
EPS:
-0.36
Netto-Cashflow:
$-14.70M
1W Leistung:
+0.48%
1M Leistung:
+3.62%
6M Leistung:
+6.97%
1J Leistung:
-7.89%
1-Tages-Spanne:
$0.6586
$0.7289
1-Wochen-Bereich:
$0.64
$0.7289
52-Wochen-Spanne:
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Firmenname
VolitionRX Ltd
Sektor
Branche
Telefon
646 650 1351
Adresse
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Vergleichen Sie VNRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.6632 | 74.24M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-02-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-02-17 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-16 | Eingeleitet | Maxim Group | Buy |
| 2018-05-14 | Bestätigt | The Benchmark Company | Buy |
| 2016-09-07 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-02-01 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
Veterinary Oncology Market Shares, Competition and Trends - GlobeNewswire
VolitionRx Limited stock prediction for this weekQuarterly Trade Summary & Verified Short-Term Plans - Newser
Trend analysis for VolitionRx Limited this weekDividend Hike & Low Drawdown Trading Strategies - Newser
Price momentum metrics for VolitionRx Limited explained2025 Performance Recap & Growth-Oriented Investment Plans - Newser
Ranking VolitionRx Limited among high performing stocks via toolsTrade Ideas & AI Optimized Trading Strategy Guides - Newser
What technical models suggest about VolitionRx Limited’s comeback2025 Historical Comparison & Entry Point Strategy Guides - Newser
VolitionRx Ltd. Earnings Call: Key Insights and Challenges, Cost Reduction, Revenue Growth, and Promising Clinical Study Outcomes Amid Uncertainty - AInvest
Combining machine learning predictions for VolitionRx Limited2025 Top Gainers & Daily Price Action Insights - Newser
How to forecast VolitionRx Limited trends using time series2025 Technical Patterns & Risk Controlled Swing Alerts - Newser
VolitionRx : Corporate Presentation September 2025 - MarketScreener
Can VolitionRx Limited rally from current levels2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Developing predictive dashboards with VolitionRx Limited dataTrade Exit Summary & High Accuracy Trade Alerts - Newser
VolitionRx Ltd. Earnings Call: Key Insights and Challenges - TipRanks
Using AI based signals to follow VolitionRx Limited2025 Major Catalysts & High Conviction Trade Alerts - Newser
What earnings revisions data tells us about VolitionRx LimitedTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
What to do if you’re stuck in VolitionRx LimitedMarket Performance Report & Stock Portfolio Risk Control - Newser
Tools to monitor VolitionRx Limited recovery probabilityLong Setup & Weekly Watchlist of Top Performers - Newser
Should I add VolitionRx Limited stock to my portfolioDollar Strength & Weekly Top Stock Performers List - sundaytimes.kr
Analyzing drawdowns of VolitionRx Limited with statistical tools2025 Geopolitical Influence & Low Risk High Win Rate Picks - Newser
Using data tools to time your VolitionRx Limited exitJuly 2025 Action & Weekly Watchlist for Hot Stocks - Newser
Is VolitionRx Limited stock entering bullish territoryMarket Sentiment Summary & High Conviction Buy Zone Picks - Newser
Analyzing VolitionRx Limited with risk reward ratio chartsBear Alert & Expert Curated Trade Setups - Newser
What risks could impact VolitionRx Limited stock performanceWeekly Stock Summary & Expert Approved Momentum Trade Ideas - Newser
Applying big data sentiment scoring on VolitionRx LimitedMarket Growth Report & Fast Moving Stock Trade Plans - Newser
Key resistance and support levels for VolitionRx LimitedIndex Update & Safe Swing Trade Setup Alerts - Newser
Should you wait for a breakout in VolitionRx LimitedJuly 2025 Recap & Low Risk Growth Stock Ideas - Newser
Real time social sentiment graph for VolitionRx LimitedJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Finanzdaten der VolitionRX Ltd-Aktie (VNRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):